StockData
Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp. (MDNAF) stock

MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2023, năm kết thúc ngày Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)

Close on Oct 19, 2026

Medicenna Therapeutics r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2023 it was C$9.30M, down 36.8% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2023Mar 31, 2023C$9.30M-36.8%
FY2022Mar 31, 2022C$14.72M+35.4%
FY2021Mar 31, 2021C$10.87M+85.2%
FY2020Mar 31, 2020C$5.87M–

More Medicenna Therapeutics figures

See a number that looks wrong?